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ABSTRACT
Background As a result of the epigenetic
phenomenon of X chromosome inactivation (XCI) every
woman is a mosaic of cells with either an inactive
paternal X chromosome or an inactive maternal X
chromosome. The ratio between inactive paternal and
maternal X chromosomes is different for every female
individual, and can inﬂuence an X-encoded trait or
disease. A multitude of X linked conditions is known,
and for many of them it is recognised that the
phenotype in affected female carriers of the causative
mutation is modulated by the XCI ratio. To predict
disease severity an XCI ratio is usually determined in
peripheral blood samples. However, the correlation
between XCI ratios in peripheral blood and disease
affected tissues, that are often inaccessible, is poorly
understood. Here, we tested several tissues obtained
from autopsies of 12 female individuals for patch size
and XCI ratio.
Methods XCI ratios were analysed using methyl-
sensitive PCR-based assays for the AR, PCSK1N and
SLITRK4 loci. XCI patch size was analysed by testing the
XCI ratio of tissue samples with decreasing size.
Results XCI patch size was analysed for liver, muscle,
ovary and brain samples and was found too small to
confound testing for XCI ratio in these tissues. XCI ratios
were determined in the easily accessible tissues, blood,
buccal epithelium and hair follicle, and compared with
ratios in several inaccessible tissues.
Conclusions Buccal epithelium is preferable over
peripheral blood for predicting XCI ratios of inaccessible
tissues. Ovary is the only inaccessible tissue showing a
poor correlation to blood and buccal epithelium, but has
a good correlation to hair follicle instead.
INTRODUCTION
Female XX mammals equalise their X chromo-
somal gene dosage to XY men by inactivating one
of their two X chromosomes in a process called X
chromosome inactivation (XCI).1 XCI is initiated
early during embryonic development, and once the
inactive X chromosome (Xi) is established it is pro-
pagated through a near inﬁnite number of cell divi-
sions. As a result every woman is a mosaic of cells
with an inactive paternal X chromosome (Xp) and
cells with an inactive maternal X chromosome
(Xm).2 XCI mosaicism will be organised in clones
of cells that have the same Xi. The size of these
clones, or XCI patches, might differ between
tissues and depends on the number of cells present
at the moment of XCI, and the extent of cell
migration. To assess XCI mosaicism most studies
use the ratio between cells with a different active X
chromosome in a population of cells largely
exceeding the patch size. This X inactivation ratio
(XIR) will be approximately 50:50 in most women,
but deviations from this 50:50 XIR are common.
When 80% of cells have the same Xi this is termed
skewed XCI, while for extremely skewed XCI over
90% of cells should have the same Xi.3 4
A skewed XIR can be caused by conditions that
inﬂuence the XCI process itself, resulting in
primary skewed XCI, or as a result of secondary
cell selection. Primary skewed XCI occurs around
gastrulation of the early embryo, when XCI is
initiated. Initiation of XCI is a stochastic process,
resulting in a cell autonomous random choice of
which X chromosome will be inactivated. After
establishing an Xi, the silent state of this X
chromosome will be clonally passed on to all
daughter cells. The random nature of this choice
makes most female embryos end up with a ratio of
50:50. By coincidence, the majority of cells can
inactivate the same X chromosome, resulting in
primary skewed XCI. The chance of this happening
increases if the cell population undergoing XCI is
smaller in size.5 6 Primary skewed XCI can also be
caused by mutations or variations in the genes
involved in the inactivation process.7 8 Secondary
skewed XCI is the result of postinactivation cell
selection that occurs when there is a selective pres-
sure for a heterozygous X linked gene. Such a
selection can occur at any age, in all tissues or
might be tissue-speciﬁc. Secondary skewed XCI
might also be the result of a decreasing stem cell
pool during life, increasing the chance that most
stem cells have the same Xi.9
A skewed XIR is clinically important whenever
an X chromosomally encoded trait or disease is
involved. By inactivating predominantly the healthy
or the mutated allele, skewing of XCI can modulate
the severity of an X linked disease. This has been
established for fragile X syndrome, where the full
mutation does not affect cell viability, but only cell
functioning. Conversely, an X encoded mutation
can also induce secondary skewed XCI. This can be
clearly seen in incontinentia pigmenti, where cells
with an active IKBKG mutation are more prone to
undergo apoptosis. For some conditions women
carrying the mutation might even appear to be
unaffected, because they display completely skewed
XCI. Despite the correlation between disease sever-
ity and skewed XCI, the mechanism through which
this skewing is achieved remains unclear for some
diseases.10–12 Currently, clinical analysis of the XIR
is widely used to explain disease severity in female
carriers of X linked diseases, or to predict disease
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severity in women with a heterozygous X linked recessive
disease, like fragile X syndrome, Barth syndrome or Rett
syndrome.
Interestingly, there are also several clinical conditions for
which no causative X linked locus has been identiﬁed, but that
have been associated with skewed XCI. This association has, for
example, been shown for autoimmune thyroiditis, where it is
thought that female individuals with extremely skewed XIR can
develop autoimmunity to self-antigens encoded by the
X chromosome that is inactive in the majority of cells.13 14 Also
for polycystic ovary syndrome (PCOS) skewed XCI is thought
to play a role in its aetiology, by preferentially inactivating the
less sensitive androgen receptor (AR) gene and thereby contribu-
tion to the hyperandrogenaemic phenotype. However, both
these associations are still under discussion.
When analysing the XIR to assess or predict the severity of an
X linked disease, the tissue being tested should have a high
degree of correlation with the affected tissue. A complicating
factor is that secondary skewed XCI might occur mainly in the
disease affected tissue without affecting other tissues. Peripheral
blood is most commonly used for testing the XIR, but its corres-
pondence to other tissues has been investigated only infrequently.
Other easily accessible tissues, such as buccal epithelium and hair
follicles have scarcely been evaluated. One previous study per-
formed an elaborate comparison between several tissues using
autopsy samples. However, a direct comparison to blood was not
performed, because blood samples were only available in a
limited number of individuals, and instead XCI patterns from
spleen were also used to represent blood.15 In the present study,
we test the correlation between the easily accessible tissues,
blood, buccal swab and hair follicles, and a number of inaccess-
ible tissues (thyroid, heart, liver, kidney, muscle and ovary), using
samples collected during autopsy of 12 female individuals.
RESULTS
Before testing the XIR of several tissues, we veriﬁed that our
analysis is not confounded by the XCI patch size. If a sample
taken for XIR analysis consists largely of a single clone, or
patch, the observed XIR does not represent the XIR of that
tissue, but rather the contribution of the patch to the analysed
sample. To exclude an inﬂuence of patch size on XIR analysis,
we attempted to identify the patch size for different tissues by
determining the XIR for tissue samples with decreasing size.
A sample composed entirely of a single patch will have the same
X chromosome inactive in all cells, instead of a mixture of
both X chromosomes. Liver and muscle were used ﬁrst to deter-
mine patch size, because these organs have a homogeneous
structure. Liver is mainly comprised of hepatocytes and muscle
mainly of myocytes, and both tissues have relatively little con-
tamination of other cell types that could possibly affect the XIR.
An organ-speciﬁc XIR, to which the test samples could be com-
pared, was determined by taking the average of three samples of
approximately 6 mm3 from different sites of each tissue frag-
ment. Liver samples used to determine patch size were obtained
from four individuals and were 0.008–0.064 mm3 in size, con-
taining 17 000–100 000 cells. Sensitivity tests of the human
androgen receptor assay (HumARA) on samples of equal size,
using male DNA and female DNA with a known XIR of 10%,
conﬁrmed that the assay provides a reliable XIR in this range of
cell number (data not shown). When using the threshold for
extremely skewed XCI (below 10% and above 90%) to identify
an XCI patch, no sample encompassing a patch could be
detected (ﬁgure 1A). Muscle samples contained a lower number
of cells, ranging from 700 cells to 46 000 cells. Since striated
muscle consists of multinucleated cells, the calculated cell
number does not represent the actual number of cells, but
instead represents the number of nuclei in a sample. The
Figure 1 X inactivation ratios compared with number of cells. Patch size analysis for: (A) liver samples of four different individuals (B) muscle
samples from three individuals (C) brain samples of three individuals (D) ovarian samples samples from three individuals. The left part of the graph
shows the X inactivation ratio plotted against the number of cells. Different symbols represent different individuals. The right part of the graph
shows the tissue-speciﬁc X inactivation ratio determined for each individual, as determined from three larger samples. Error bars show 2 SDs from
the tissue-speciﬁc average.
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amount of nuclei reﬂects the number of cells that have fused to
one or more multinucleated cells. Although the term ‘nuclei’
might be more appropriate, for convenience we will use the
term ‘cells’ instead. Also for muscle skewed XCI was not
observed, but, several samples showed a clear deviation from
the tissue-speciﬁc XIR in one individual. This deviation
occurred in the range of 4000 cells to 6000 cells (ﬁgure 1B),
possibly indicating that these samples approach the patch size in
muscle.
Next, patch size analysis was performed for brain and ovary,
because of the clinical relevance of these tissues. The XCI pat-
terns in brain are of particular clinical relevance, because the
X chromosome is relatively enriched for genes involved in neur-
onal functioning.16 Samples obtained from cerebral cortex con-
tained 3000 cells to 100 000 cells, but did not display an
extremely skewed XIR, nor a clear deviation from the tissue-
speciﬁc XIR (ﬁgure 1C). Ovarian patch size is of clinical import-
ance for ovarian phenotypes involving hyperandrogenism, such
as PCOS. Ovarian samples for patch size analysis were isolated
from the cortical region using laser microdissection to ensure
they did not contain any follicles or vascular structures with
possible oligoclonal expansion. The obtained samples were
0.001–0.002 mm3 in size and contained 7000 cells to 75 000
cells. No skewed XCI was observed in these samples, indicating
that the patch size in the ovarian cortex is less than 7000 cells
(ﬁgure 1D). These results show that the patch sizes for liver,
muscle, brain and ovary are smaller than 17 000 cells, 6000
cells, 3000 cells and 7000 cells, respectively. A sample of 1 mm3
will therefore be large enough to measure XIR, without being
biased by patch size.
After validating that patch size does not affect skewing ana-
lyses, we compared XIRs between different human tissues. We
obtained tissues from 12 female individuals, with a median age
of 58 years (table 1). Cause of death varied from blood loss, to
infection or sepsis and complications of an organ transplant-
ation. Of the 12 individuals from whom tissue samples were
collected, 9 were informative for the AR locus. To analyse XCI
in all 12 individuals we used the assays designed by Bertelsen
et al, that are based on a technique similar to the HumARA, but
use a methyl-sensitive HpaII site in proximity of a dinucleotide
repeat in the PCSK1N and SLITRK4 genes.17 The PCSK1N and
SLITRK4 assays were informative in 7 of 12 and 8 of 12 indivi-
duals, respectively, which is a slightly lower frequency of hetero-
zygosity than the 75% and 80% observed by Bertelsen et al.17
After performing the three assays on all informative tissue
samples, we tested the correlation between the three assays in
our samples. For the AR and PCSK1N assays we found a
Pearson correlation coefﬁcient of 0.80, for the AR and
SLITRK4 assays 0.64, and for the PCSK1N and SLITRK4
assays 0.81, indicating a good correlation between the three
assays (ﬁgure 2).
For testing the XIRs between different tissue samples, we used
the average XIR from all informative assays. When XIRs are
compared between tissues of an individual they cluster together,
although there is considerable variation between tissues
(ﬁgure 3). The largest observed difference between two tissues of
the same individual was 58.8% between blood and thyroid of
individual 4. The average difference between all tissues within
one individual ranged from 6.9% in individual 7 to 17.2%
in individual 4. Information regarding infection and blood
Table 1 Characteristics of individuals from whom autopsy samples were obtained
Individual
Age
(years)
Time between
death and
DNA sampling
(hrs) Cause of death
Erythrocyte
transfusion
Monoclonal
diseases
Cytostatic
therapy Sepsis
Tissues
not in
analysis AR PCSK1N SLITRK4
1 57 3 Blood loss On day of
death
Squamous
carcinoma of
oesophagus
Yes, until
4 months
before death
No I I I
2 67 50 Mesenteric
ischaemia
4 days before
death
No No No I I I
3 45 25 Meningitis No No No No I I I
4 85 33 Myocardial
infarction
No No No No I I NI
5 63 51 Complications of
lung
transplantation
10 days before
death
No No Yes I I NI
6 44 56 Cardiac failure No No No No I NI I
7 1 22 Pneumonia On day of
death
No No Yes I NI I
8 59 28 Multiorgan
failure, sepsis
1 day before
death
No No Yes NI I I
9 51 66 Myocardial
infarction
On day of
death
No No No Liver,
transplant
NI I I
10 66 24 Metastatic
monoclonal
disease
18 days before
death
Squamous cell
carcinoma of the
bladder
No No I NI NI
11 46 20 Complications of
liver
transplantation
1 day before
death
No No Yes Liver,
transplant
I NI NI
12 62 19 Myocardial
infarction
No No No No Heart NI NI I
In columns AR, PCSK1N and SLITRK4 ‘I’ denotes if an individual was informative for the respective assay, ‘NI’ means the individual was not informative.
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transfusion was documented, because theoretically these condi-
tions could be accompanied by proliferation of a subpopulation
of lymphocytes, possibly resulting in a secondary skewed XCI in
blood. Also, occurrence of monoclonal diseases and administra-
tion of cytostatic drugs was documented, since these conditions
could also theoretically result in the selective increase of a subpo-
pulation of cells in any tissue. No clear pattern was observed
between these conditions and the occurrence of skewed XCI
>90% in a single tissue or in multiple tissues.
The correlation of the easily accessible tissues to the inaccess-
ible tissues was tested using Pearson’s correlation coefﬁcient.
Using blood as easily accessible tissue, a good correlation was
found with liver (r=0.58, p=0.078), kidney (r=0.50, p=0.097)
and buccal epithelium (r=0.70, p=0.016) (table 2 and see
online supplementary ﬁgure S1). When buccal epithelium was
used as easily accessible tissue a much stronger correlation
(r>0.68) was found with all tissues, except for ovary and hair,
and for several tissues this correlation was signiﬁcant.
Surprisingly, blood and buccal epithelium have a weak correl-
ation with the ovarian XIR (r=0.18 and r=0.23, respectively).
Instead, hair follicles show a strong correlation to ovarian XIR
(r=0.77, p=0.005), while for all other inaccessible tissues there
is a weak correlation (r<0.40) with hair follicles.
Since long it has been described that there is an age-related
increase of skewing in blood, occurring above the age of 60
years.4 18 19 This has been attributed to oligoclonal expansion
from a limited number of stem cells, an effect that might be
increased by a possible decrease of the number of stem cells in
older women.4 9 If this is true, it can be expected that within a
female individual the XIRs of different tissues initially cluster
Figure 2 Correlation between the three assays used for analysing X chromosome inactivation (XCI): AR, PCSK1N and SLITRK4 (A) Plot showing the
correlation between the X inactivation ratio (XIR) obtained by analysing the AR and PCSK1N loci for each tissue of all informative individuals using a
Pearson correlation coefﬁcient. (B) Plot showing the correlation between the XIR obtained by analysing the AR and SLITRK4 loci for each tissue of
all informative individuals using a Pearson correlation coefﬁcient. (C) Plot showing the correlation between the XIR obtained by analysing the
PCSK1N and SLITRK4 loci for each tissue of all informative individuals using a Pearson correlation coefﬁcient.
Figure 3 X inactivation ratio (XIR) analysis in all accessible and inaccessible tissues of female individuals. Each data point represents the average
XIR value from the assays informative in an individual. For every assay PCRs were performed in triplicate. Error bars represent the SD from the
assays that were used. Different tissues are represented by different symbols. The table below shows which assays were informative for each
individual.
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together around the same value, but diverge at later ages. To test
if tissue-speciﬁc XIRs within an individual diverge with increas-
ing age, the average XIR difference was calculated from the XIR
differences for every tissue combination within an individual.
The average XIR difference is the smallest in the youngest indi-
vidual and the largest in the oldest individual and showed a sig-
niﬁcant correlation with age (r=0.72, p=0.008) (see online
supplementary ﬁgure S2). These data suggest that XIRs of dif-
ferent tissues within an individual diverge with increasing age,
although a larger number of individuals will be required to
conﬁrm this hypothesis.
DISCUSSION
We performed a XIR-based patch size analysis for several
inaccessible tissues, to avoid XIR analyses being confounded by
XCI patch size. The results obtained show that the patch size
for liver, muscle, brain and ovary is smaller than 17 000 cells,
6000 cells, 3000 cells and 7000 cells, respectively. These results
are consistent with results from previous studies, that have all
been performed on epithelial layers. Most of these studies used
a mutation in the glucose-6-phosphate dehydrogenase (G6PD)
gene, to stain tissue sections for the presence of G6PD activity.
These studies estimated the patch size of endothelium in the
arterial wall to be 50 cells of the epidermis, to be smaller than
30 mm2, and smaller than 1 mm2 in hair follicles.20–22 Another
study employed the HumARA to assess patch size in bladder
urothelium and estimated the patch size to be 120 mm2.23
Unlike in some of the abovementioned studies we did not iden-
tify an XCI patch in our samples, although our sample sizes
were in the same range or smaller. A possible explanation is that
epithelium has a larger patch size, compared with tissues that
contain a mixture of parenchyma and stromal cells, as paren-
chyma and stromal cells might have already originated from dif-
ferent embryonic germ layers with different XIRs.
While the HumARA assay is probably the most widely used
assay to determine the XIR, the AR locus is not informative for
every individual. To analyse the XIR in all individuals, we used
recently published assays for the SLITRK4 and PCSK1N loci
alongside the HumARA. Like the HumARA, these assays deter-
mine XCI by assessing the methylation status of a locus neigh-
bouring a polymorphic repeat. A methylation sensitive
restriction enzyme is used to digest unmethylated DNA, leaving
methylated templates intact, which are subsequently ampliﬁed
by PCR. The ampliﬁed polymorphic repeat is used to discrimin-
ate between the two alleles. Although a strong correlation was
found between all three assays, the three assays do not always
perfectly agree. The average difference between two assays was
6.4% for the AR and PCSK1N assays, 6.2% for AR and
SLITRK4, and 4.8% for PCSK1N and SLITRK4. The largest
observed difference comparing all three assays was 27.1%, in
blood of patient 2. This difference in XIR between the assays
might be explained by the low number of methylation sites that
are analysed. When using only one (PCSK1N and SLITRK4) or
two (AR) methylation sites, this might not always reﬂect the
methylation status of the complete locus. Indeed, it was shown
for the HumARA that DNA methylation not always corresponds
to relative expression of the two alleles.24 Expression of the
PCSK1N and SLITRK4 loci has not been compared with methy-
lation status, but instead with AR methylation.17 Theoretically,
the three assays may also differ because of tissue-speciﬁc gene
silencing, independent of X inactivation status. Altogether, this
difference shows that analysing a single methylation site might
not be representative for the inactive status of an entire X
chromosome, and using three loci increases reliability.
The tissues that were used in this study were collected during
autopsies of women that died of various causes, and theoretically
several clinical conditions might affect the XIR of different
tissues. In case of cancer or cytostatic therapy the XIR of all ana-
lysed tissues could theoretically be affected. Any tissue could be
affected by cancer, altering the XIR through monoclonal expan-
sion of the primary tumour or metastases. In addition, cytostatic
therapy could also affect any tissue by dramatically reducing the
number of stem cells, resulting in oligoclonal expansion and a
secondary skewed XIR. In both conditions the expected result
would be a shift of the XIR towards extremely skewed XCI,
which was not observed. In several other individuals, the T
lymphocyte composition in peripheral blood, that was used to
assess XIR, could have been altered. First, the occurrence of
infection and sepsis is likely to alter T lymphocyte composition
in the peripheral blood samples analysed. However, this is not
likely to skew the XIR, as this would require an oligoclonal
expansion of thymocytes and during an immune response a
larger number of thymocytes will be activated. Therefore, it can
be considered unlikely that infection or sepsis will affect the XIR.
Second, after major blood loss the peripheral T lymphocyte
population is largely lost and needs to be replaced. However, as
the peripheral T lymphocyte population is a reﬂection of the
stem cell population, it is not likely that the population of newly
circulating T lymphocytes will have a different XIR. An erythro-
cyte transfusion will not affect the XIR of a peripheral blood
sample, as erythrocytes are enucleated cells. In none of the indivi-
duals suffering from any of the conditions that could alter the
peripheral T lymphocyte population extremely skewed XCI was
observed. Although this argues against an oligoclonal expansion,
we cannot exclude that these conditions have affected the XIR of
peripheral blood to a small degree.
The comparison of tissue-speciﬁc XIRs yielded an interesting
correlation pattern for hair follicle, as hair follicles display a weak
correlation with all inaccessible tissues, except ovary.
Contradictory to our results, a previous study analysed XIRs in
hair follicles of 21 individuals and found a signiﬁcant correlation
to blood XIR (r=0.67; p=0.009).25 One possible explanation for
this difference is the number of hair follicles used to assay XCI.
We used 20 hair follicles, where Kaupert et al used 3–4 follicles to
assay XCI. Hair follicles originate from a small number of precur-
sor cells, and the chance that a hair follicle is monoclonal regard-
ing XCI status has been estimated around 50%.26 Consequently,
using a smaller number of hair follicles, increases the chance that
patch size confounds XIR analysis. Given the strong correlation
between hair follicles and ovary, we conclude that when interested
Table 2 Pearson product moment correlation between XIRs of
easily accessible tissues and inaccessible tissues
Blood Buccal Hair
Blood x 0.70* 0.16
Buccal 0.70* x 0.02
Hair 0.16 0.02 x
Thyroid 0.39 0.52 0.32
Heart 0.30 0.71* 0.40
Liver 0.58 0.68* 0.05
Kidney 0.50 0.72* 0.07
Muscle 0.48 0.76** 0.21
Ovary 0.18 0.23 0.77**
*p<0.05; ** p<0.01.
XIR, X inactivation ratio.
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in the XIR of an ovary, of use in, for instance, patients with PCOS,
testing XCI in hair follicles should be preferred over testing per-
ipheral blood samples or buccal swabs.
The comparison of XIRs between easily accessible tissues,
blood and buccal swab and inaccessible tissues demonstrated
that buccal epithelium has a better correlation to inaccessible
tissues compared with blood. To date most studies analysing
skewing of XCI in single patients or patient populations use per-
ipheral blood samples for analysis. A good correlation between
XCI in blood and buccal epithelium has been reported earlier
by two studies, and is conﬁrmed by our results.19 27 However,
given the stronger correlation of buccal epithelium to all exam-
ined tissues we conclude that when testing for XCI skewing,
buccal swab should be the method of choice.
Many studies have reported an age-related increase of
skewing in blood, occurring above the age of 60 years, which
has been attributed to the oligo-clonal expansion and/or decreas-
ing number of stem cells in older women.4 9 18 19 Given the
small number of individuals included in this study we were
unable to test for an age-related increase in skewed XCI.
However, the obtained XIRs from different tissues presented a
unique opportunity to test if an age-related increase in skewed
XCI might be caused by a decreasing stem cell number. Indeed
we ﬁnd that tissue-speciﬁc XIRs within an individual diverge,
although a larger number of individuals will be required to
conﬁrm this hypothesis.
In conclusion, we show that the patch size of XCI in liver,
muscle, brain and ovary is small enough not to confound XIR
analysis of 1 mm3 biopsies. When comparing blood, buccal epi-
thelium and hair follicle as easily accessible tissues for assaying
XIR, hair follicles show the best correlation with ovary. For all
other inaccessible tissues buccal epithelium shows the best cor-
relation. Moreover a buccal swab is non-invasive, and should
therefore be considered the best and most convenient method
for determining XIR.
MATERIALS AND METHODS
All samples used in this study were obtained from the Erasmus
MC Tissue Bank, in accordance with the Dutch Law on Medical
Research and autopsy materials, and were only used for research
after permission was obtained through signed informed consent
from the next of kin. Tissue samples for comparison of tissue-
speciﬁc XIRs were collected during autopsies performed in the
Erasmus Medical Centre in Rotterdam, between June 2012 and
August 2014. Tissue samples were snap frozen and DNA was
extracted using phenol-chloroform puriﬁcation. Blood samples
could not be extracted by peripheral vein puncture and were
therefore obtained through cardiac puncture. Ovarian samples
for XIR analysis were cut by hand from the ovarian cortex, only
selecting regions that did not contain any visible follicles.
Samples for patch size analysis were obtained by cutting cryo-
sections of 8 mm thick, from which ﬁnal samples were cut by
hand measuring 1–8 mm2. DNA was isolated using phenol-
chloroform extraction. The number of cells in each sample was
calculated back from the total amount of DNA present, assum-
ing a single cell contains 6 pg DNA. Ovarian samples for patch
size analysis were obtained during autopsies of three female
individuals of premenopausal age. Samples 0.10–0.16 mm² were
isolated from 14 mm cryosections using a laser microdissection
microscope (Carl Zeiss PALM Microbeam).
XIRs were analysed by ampliﬁcation of polymorphic repeats in
the AR, SLITRK4 and PCSK1N loci. DNA samples were digested
with the methyl-sensitive restriction enzyme HpaII and EcoRI, or
EcoRI alone for 24 h at 37°C, followed by inactivation of the
enzyme by incubating at 80°C for 25 min. The CAG repeat in the
AR locus was ampliﬁed using primers TGCAGTTAGGG
CTGGGAAGG and CTGTGGGGCCTCTACGATGG. The AC
repeat in the SLITRK4 gene was ampliﬁed using primers
GCACACAAGCAGTCCTTCCT and TGGCTTCTTGGTTG
CTCTCT. The tandem CA and AG repeat of PCSK1N was amp-
liﬁed using primers ATGCGAAGACCATTCCCTCT and
GTGCGTGTGATGTGAGGAGA. The ampliﬁed products were
analysed separately on an ABI3130 genetic analyser. Correlations
of XIRs between different tissues were calculated using Pearson’s
correlation coefﬁcient. All individuals were pooled in a single
group, regardless of their age and menopausal status.
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